FDA Approves Alzheimer's Drug, Clearing Way for Medicare Coverage

Source: PBS HealthU.S. officials granted full approval to a closely watched Alzheimer's drug on Thursday, clearing the way for Medicare and other insurance plans to cover the treatment. The Food and Drug Administration endorsed the IV-administered drug, Leqembi, for patients with mild dementia and other symptoms caused by Alzheimer's disease. Although its benefits are modest, Leqembi is the first medicine that's been shown to significantly slow Alzheimer's...